Clinical Trial Update: Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

This update describes a Phase 2 trial evaluating paclitaxel plus GM-CSF in patients with unresectable stage III or IV melanoma. The study status is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Paclitaxel (Taxol) (paclitaxel)
• Sargramostim (Leukine) (sargramostim)

Snippet

Sponsor: University of Virginia | Conditions: Melanoma (Skin) | Phase 2 | Status: SUSPENDED